Stocktoria
VIVOS INC RDGL
OTC · OOTC · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2001-08-08
VIVOS INC (RDGL) earns a Piotroski F-score of 2/9 (weak financial health). It does not currently pay a dividend. FY2025 revenue was $68,379 at a -4483.9% net margin.
2/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Price from month-end closes (Yahoo) — for reference, not real-time.
Revenue trend · last 8y · up
How it ranks in Manufacturing · percentile among 1829 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 2/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Detailed pages
Sector peers · similar-size Manufacturing companies
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| RDGL | VIVOS INC | 2/9 | — | — | — |
| PAVM | PAVmed Inc. | 3/9 | — | 90.2 | — |
| GUTS | FRACTYL HEALTH, INC. | 2/9 | -16.47 | — | — |
| AMIX | Autonomix Medical, Inc. | 1/9 | — | — | — |
| ADGM | Adagio Medical Holdings, Inc. | 1/9 | -8.39 | — | — |
| SKYA | SkyAI, Inc. | 3/9 | — | — | — |
| FOFA | FAMILY OFFICE OF AMERICA, INC. | 2/9 | -13.31 | — | — |
FAQ
Is RDGL financially healthy?
VIVOS INC's Piotroski F-score is 2/9 (8–9 is excellent, 0–3 weak).
Does RDGL pay a dividend?
No, VIVOS INC does not currently pay a dividend.
How profitable is RDGL?
In FY2025, VIVOS INC had a net margin of -4483.9% and a return on equity of -184.6%.
Source: SEC EDGAR filings · CIK 0001449349 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.